Legal & General Group PLC Fibrogen Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $57,440 - $205,766	-72,709 Reduced 90.98%	7,212 $6,000
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $7,975 - $65,949	-3,203 Reduced 3.85%	79,921 $215,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $83,259 - $131,439	5,220 Added 6.7%	83,124 $1.55 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $34,143 - $45,619	2,573 Added 3.42%	77,904 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $16,347 - $20,936	1,434 Added 1.94%	75,331 $980,000
Q2 2022 Aug 22, 2022	SELL	$7.94 - $12.96 $13,609 - $22,213	-1,714 Reduced 2.27%	73,897 $781,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $9,291 - $12,978	773 Added 1.03%	75,611 $909,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $3,306 - $5,124	333 Added 0.45%	74,838 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $163,541 - $427,971	16,065 Added 27.49%	74,505 $761,000
Q2 2021 Aug 12, 2021	BUY	$18.57 - $35.68 $41,522 - $79,780	2,236 Added 3.98%	58,440 $1.56 Million
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $15,376 - $27,637	496 Added 0.89%	56,204 $1.95 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $296,682 - $391,711	7,999 Added 16.77%	55,708 $2.07 Million
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $140,714 - $158,203	-3,477 Reduced 6.79%	47,709 $1.96 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $152,427 - $200,444	4,680 Added 10.06%	51,186 $2.08 Million
Q1 2020 May 14, 2020	SELL	$23.3 - $45.96 $69,480 - $137,052	-2,982 Reduced 6.03%	46,506 $1.62 Million
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $257,240 - $357,518	7,439 Added 17.69%	49,488 $2.12 Million
Q3 2019 Nov 13, 2019	BUY	$36.98 - $48.45 $159,014 - $208,335	4,300 Added 11.39%	42,049 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $103,352 - $163,369	-2,942 Reduced 7.23%	37,749 $1.71 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $412,966 - $577,652	9,642 Added 31.05%	40,691 $2.21 Million
Q4 2018 Feb 15, 2019	BUY	$37.97 - $60.16 $165,207 - $261,756	4,351 Added 16.3%	31,049 $1.44 Million
Q3 2018 Nov 20, 2018	SELL	$56.3 - $67.25 $56 - $67	-1 Reduced -0.0%	26,698 $1.62 Million
Q2 2018 Aug 10, 2018	SELL	$44.9 - $64.95 $39,107 - $56,571	-871 Reduced 3.16%	26,699 $1.67 Million
Q1 2018 May 17, 2018	SELL	$45.35 - $61.65 $97,683 - $132,794	-2,154 Reduced 7.25%	27,570 $1.27 Million
Q4 2017 Feb 13, 2018	BUY	$41.95 - $60.1 $1.25 Million - $1.79 Million	29,724	29,724 $1.42 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account